[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.161.241.199. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
August 13, 1997

Concern Expressed About FDA Reform Legislation

JAMA. 1997;278(6):459. doi:10.1001/jama.1997.03550060027011

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.

Abstract

FOUR Washington, DC—based consumer groups have joined to protest the current draft legislation aimed at reforming the Food and Drug Administration (FDA). The groups describe the proposals as a step backward in the regulation of safe and effective drugs. They also charge that the process by which Senate bill S-830 has reached the Senate floor is flawed because no public hearings were held on many of its provisions.

The committee "did not hold a public hearing before reporting the bill favorably to the Senate. That was wrong. This bill is too important to slide through without a public hearing," said former Democratic Ohio senator Howard Metzenbaum, chair of the Consumer Federation of America. He added, "The bill would be harmful to the nation's health; it moves protective health machinery backwards." The other organizations joining the consumer federation in protest were Project Inform, the Center for Science in the Public Interest

×